Literature DB >> 23747283

High-throughput compatible fluorescence resonance energy transfer-based assay to identify small molecule inhibitors of AMSH deubiquitinase activity.

Jamie L Arnst1, Christopher W Davies, Srikumar M Raja, Chittaranjan Das, Amarnath Natarajan.   

Abstract

Deubiquitinases (DUBs) play an important role in regulating the ubiquitin landscape of proteins. The DUB AMSH (associated molecule with the SH3 domain of STAM) has been shown to be involved in regulating the ubiquitin-dependent down-regulation of activated cell surface receptors via the endolysosomal degradative pathway. Therefore, small molecule AMSH inhibitors will be useful chemical probes to study the effect of AMSH DUB activity on cell surface receptor degradation. Currently, there are no known selective inhibitors of AMSH or high-throughput compatible assays for their identification. We report the development and optimization of a novel fluorescence resonance energy transfer (FRET)-based add-and-read AMSH DUB assay in a 384-well format. In this format, the optimal temperature for a high-throughput screen (HTS) was determined to be 30°C, the assay tolerates 5% dimethyl sulfoxide (DMSO), and it has a Z-score of 0.71, indicating HTS compatibility. The assay was used to show that AMSH selectively cleaves Lys63-linked diubiquitin over Lys48- and Lys11-linked diubiquitin. The IC50 value of the nonspecific small molecule DUB inhibitor N-ethylmaleimide was 16.2±3.2 μM and can be used as a qualitative positive control for the screen. We conclude that this assay is high-throughput compatible and can be used to identify novel small molecule inhibitors of AMSH.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AMSH; Deubiquitinase assay; FRET; HTS

Mesh:

Substances:

Year:  2013        PMID: 23747283      PMCID: PMC3784021          DOI: 10.1016/j.ab.2013.05.017

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  31 in total

1.  A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays.

Authors: 
Journal:  J Biomol Screen       Date:  1999

Review 2.  Endocytosis: the DUB version.

Authors:  Michael J Clague; Sylvie Urbé
Journal:  Trends Cell Biol       Date:  2006-09-22       Impact factor: 20.808

Review 3.  Deubiquitinating enzymes as novel anticancer targets.

Authors:  Benjamin Nicholson; Jeffrey G Marblestone; Tauseef R Butt; Michael R Mattern
Journal:  Future Oncol       Date:  2007-04       Impact factor: 3.404

Review 4.  Breaking the chains: structure and function of the deubiquitinases.

Authors:  David Komander; Michael J Clague; Sylvie Urbé
Journal:  Nat Rev Mol Cell Biol       Date:  2009-08       Impact factor: 94.444

Review 5.  The emerging complexity of protein ubiquitination.

Authors:  David Komander
Journal:  Biochem Soc Trans       Date:  2009-10       Impact factor: 5.407

Review 6.  Regulation of endocytic sorting by ESCRT-DUB-mediated deubiquitination.

Authors:  Michelle H Wright; Ilana Berlin; Piers D Nash
Journal:  Cell Biochem Biophys       Date:  2011-06       Impact factor: 2.194

7.  Possible involvement of a novel STAM-associated molecule "AMSH" in intracellular signal transduction mediated by cytokines.

Authors:  N Tanaka; K Kaneko; H Asao; H Kasai; Y Endo; T Fujita; T Takeshita; K Sugamura
Journal:  J Biol Chem       Date:  1999-07-02       Impact factor: 5.157

8.  AMSH interacts with ESCRT-0 to regulate the stability and trafficking of CXCR4.

Authors:  Maria I Sierra; Michelle H Wright; Piers D Nash
Journal:  J Biol Chem       Date:  2010-02-16       Impact factor: 5.157

Review 9.  Deubiquitinases in cancer: new functions and therapeutic options.

Authors:  J M Fraile; V Quesada; D Rodríguez; J M P Freije; C López-Otín
Journal:  Oncogene       Date:  2011-09-26       Impact factor: 9.867

10.  AMSH is an endosome-associated ubiquitin isopeptidase.

Authors:  John McCullough; Michael J Clague; Sylvie Urbé
Journal:  J Cell Biol       Date:  2004-08-16       Impact factor: 10.539

View more
  7 in total

Review 1.  Otubain 1: a non-canonical deubiquitinase with an emerging role in cancer.

Authors:  Matthew Saldana; Kacey VanderVorst; Anastasia L Berg; Hyun Lee; Kermit L Carraway
Journal:  Endocr Relat Cancer       Date:  2019-01-01       Impact factor: 5.678

Review 2.  The role of deubiquitinases in breast cancer.

Authors:  Zhenna Xiao; Peijing Zhang; Li Ma
Journal:  Cancer Metastasis Rev       Date:  2016-12       Impact factor: 9.264

3.  Cell Lysate-Based AlphaLISA Deubiquitinase Assay Platform for Identification of Small Molecule Inhibitors.

Authors:  Christine A Ott; Bolormaa Baljinnyam; Alexey V Zakharov; Ajit Jadhav; Anton Simeonov; Zhihao Zhuang
Journal:  ACS Chem Biol       Date:  2017-08-24       Impact factor: 5.100

4.  The Endosome-associated Deubiquitinating Enzyme USP8 Regulates BACE1 Enzyme Ubiquitination and Degradation.

Authors:  Eniola Funmilayo Aduke Yeates; Giuseppina Tesco
Journal:  J Biol Chem       Date:  2016-06-14       Impact factor: 5.157

5.  Mechanism of recruitment and activation of the endosome-associated deubiquitinase AMSH.

Authors:  Christopher W Davies; Lake N Paul; Chittaranjan Das
Journal:  Biochemistry       Date:  2013-10-23       Impact factor: 3.162

6.  A time-resolved Förster resonance energy transfer assay to measure activity of the deamidase of the prokaryotic ubiquitin-like protein.

Authors:  Ian C Eustis; Jessica Huang; Meagan E Pilkerton; Samuel D Whedon; Champak Chatterjee
Journal:  Anal Biochem       Date:  2015-07-21       Impact factor: 3.365

7.  BACE1 elevation engendered by GGA3 deletion increases β-amyloid pathology in association with APP elevation and decreased CHL1 processing in 5XFAD mice.

Authors:  WonHee Kim; Liang Ma; Selene Lomoio; Rachel Willen; Sylvia Lombardo; Jinghui Dong; Philip G Haydon; Giuseppina Tesco
Journal:  Mol Neurodegener       Date:  2018-02-02       Impact factor: 14.195

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.